Anteo Diagnostics Ltd has released a press release.
European RAT Clinical Trial Halted to Refocus Initiatives
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- FY22 Results Announcement
- Appendix 4E Preliminary Final Report
- CEO Appointment
- AnteoX Performance Validated by Two Global Battery Companies
- Application for quotation of securities - ADO
Later from AnteoTech
- Managing Director AGM Presentation
- AnteoTech receives $3.2m R&D Tax Incentive
- Response to ASX Query
- Appendix 4D and Interim Financial Report
- AnteoTech signs MOU with Trinseo
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech